Company intelligence / Profile preview
BeyondSpring Inc.
Florham Park, New Jersey, USAbeyondspringpharma.com ↗
- Ownership
- Public · BYSI
- Development stage
- Other
01
Overview
The company’s lead asset, Plinabulin, has demonstrated significant overall survival benefit and improved quality of life in phase III trials for NSCLC patients who have failed platinum-based therapies. It also shows strong efficacy in preventing chemotherapy-induced neutropenia. Additional investigator-led studies are ongoing in SCLC and other cancers. Preclinical programs include novel immuno-oncology assets and targeted protein degraders through its subsidiary SEED Therapeutics.[8][9]
- Therapeutic areas
- OncologyNeurology
- Modalities
- Small molecules (e.g., Plinabulin, a tubulin binder and dendritic cell maturation agent)Targeted Protein Degradation (via SEED Therapeutics' molecular glue platform)
- Industry
- Biotech
02
Drug pipeline
4 assets3 more assets in the full pipeline.
03
Financials
- Market cap
- $26M
- Total revenue
- $0
- Enterprise value
- $19.6M
Beyond the preview
Go deeper on BeyondSpring Inc..
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Clinical trials
Follow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Licensing & deals
Explore licensing agreements, acquisitions, and the assets behind each deal.
- Partners
- Deal terms
- Milestones
Funding history
Trace financing activity and the investors behind a company’s development.
- Funding rounds
- Investors
- Capital raised
Competitive landscape
Compare peer pipelines by target, modality, and therapeutic area.
- Peer companies
- Targets
- Pipeline overlap
Technologies & patents
Explore technology platforms and the patent landscape around relevant assets.
- Platforms
- Patents
- Assignees
Research & analysis
Connect company news and source material to the questions you’re investigating.
- Company news
- Sources
- Analysis
Bring the full picture into focus.
See how Gosset can support your research on BeyondSpring Inc..